Clinical Trial

Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 4

Study acronym: COBRA 4
Recruiting
View on ClinicalTrials.gov →
Summary
This study investigates the impact of ∆9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on recognition memory in healthy, regular cannabis users. Participants complete the same recognition memory task after self-administering one of two different strains of cannabis flower one day and while not intoxicated another day. Event-related potentials (ERPs) are measured via electroencephalogram (EEG) during the recognition memory task. Blood is collected to quantify THC and CBD exposure. Participants also complete self-report measures of medical history, sleep quality, subjective cognitive function, physical activity, psychological functioning, substance use, and acute drug effects.
Trial Details
NCT Number NCT07679581
Lead Sponsor L. Cinnamon Bidwell
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Cannabis, Memory, Electroencephalography
Enrollment 64 participants
Start Date 2025-12-10
Primary Completion 2027-02-01 (estimated)
Study Completion 2027-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-01